Cervical cancer: Disparities in screening, treatment, and survival

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 3, 2003, Pages

  Garner, Elizabeth I O ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER PREVENTION; CANCER SCREENING; CANCER SURVIVAL; CASE REPORT; COLPOSCOPY; CONFERENCE PAPER; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE ACCESS; HUMAN; INFECTION RISK; NEGRO; OUTCOMES RESEARCH; PAPANICOLAOU TEST; PRIORITY JOURNAL; RACE DIFFERENCE; SQUAMOUS CELL CARCINOMA; UNITED STATES; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CAUSE OF DEATH; COMORBIDITY; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INCIDENCE; MASS SCREENING; SOCIOECONOMIC FACTORS; SURVIVAL RATE; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0037357889     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (90)

1. Parkin, D. M. Cancer in developing countries. Cancer Surv., 19-20: 519-561, 1994.
2. Womack, S. D., Chirenje, Z. M., Blumenthal, P. D., Gaffikin, L., McGrath, J. A., Chipato, T., Ngwalle, E., and Shah, K. V. Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe. BJOG, 107: 33-38, 2000.
3. Miller, B. A., Kolonel, L. N., Bernstein, L., Young, J. L., Swanson, G. M., and West, D. (eds.). Racial/ethnic patterns of cancer in the United States, 1988-1992, NIH Publ. No. 96-4104. Bethesda, MD: National Cancer Institute, 1996.
4. Nuovo, G. J., and Pedemonte, B. M. Human papillomavirus types and recurrent cervical warts. J. Am. Med. Assoc., 263: 1223-1226, 1990.
5. Lorincz, A. T., Reid, R., Jenson, A. B., Greenberg, M. D., Lancaster, W., and Kurman, R. J. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol., 79: 328-337, 1992.
6. Lorincz, A. T., and Reid, R. Association of human papillomavirus with gynecologic cancer. Curr. Opin. Oncol., 1: 123-132, 1989.
7. Stone, K. M. Human papillomavirus infection and genital warts: update on epidemiology and treatment. Clin. Infect. Dis., 20 (Suppl. 1): S91-S97, 1995.
8. Cuzick, J., Szarewski, A., Terry, G., Ho, L., Hanby, A., Maddox, P., Anderson, M., Kocjan, G., Steele, S. T., and Guillebaud, J. Human papillomavirus testing in primary cervical screening. Lancet, 345: 1533-1536, 1995.
9. Hildesheim, A., Gravitt, P., Schiffman, M. H., Kurman, R. J., Barnes, W., Jones, S., Tchabo, J. G., Brinton, L. A., Copeland, C., Epp, J., et al. Determinants of genital human papillomavirus infection in low-income women in Washington, D. C. Sex Transm. Dis., 20: 279-285, 1993.
10. Ho, G. Y., Bierman, R., Beardsley, L., Chang, C. J., and Burk, R. D. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med., 338: 423-428, 1998.
11. Peyton, C. L., Gravitt, P. E., Hunt, W. C., Hundley, R. S., Zhao, M., Apple, R. J., and Wheeler, C. M. Determinants of genital human papillomavirus detection in a U. S. population. J. Infect. Dis., 183: 1554-1564, 2001.
12. Ley, C., Bauer, H. M., Reingold, A., Schiffman, M. H., Chambers, J. C., Tashiro, C. J., and Manos, M. M. Determinants of genital human papillomavirus infection in young women. J. Natl. Cancer Inst. (Bethesda), 83: 997-1003, 1991.
13. Burk, R. D., Kelly, P., Feldman, J., Bromberg, J., Vermund, S. H., DeHovitz, J. A., and Landesman, S. H. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis., 23: 333-341, 1996.
14. Sherman, M. E., and Kelly, D. High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression? Mod. Pathol., 5: 337-342, 1992.
15. Jones, H. W. J., and Jones, G. S. Gynecology. Baltimore, MD: Williams and Wilkins, 1982.
16. Cox, J. T. The epidemiology of CIN: what is the role of HPV? In: H. W. Jones (ed.), Balliere's Clinical Obstetrics and Gynecology, pp. 1-37. London: Balliere Tindall Publishers, 1995.
17. Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis., 169: 235-240, 1994.
18. Lazcano-Ponce, E., Herrero, R., Munoz, N., Cruz, A., Shah, K. V., Alonso, P., Hernandez, P., Salmeron, J., and Hernandez, M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int. J. Cancer, 91: 412-420, 2001.
19. Maiman, M. Management of cervical neoplasia in human immunodeficiency virus-infected women. J. Natl. Cancer Inst. Monogr, 23: 43-49, 1998.
20. Herrero, R., Brinton, L. A., Reeves, W. C., Brenes, M. M., Tenorio, F., de Britton, R. C., Gaitan, E., Garcia, M., and Rawls, W. E. Invasive cervical cancer and smoking in Latin America. J. Natl. Cancer Inst. (Bethesda), 81: 205-211, 1989.
21. Kanetsky, P. A., Gammon, M. D., Mandelblatt, J., Zhang, Z. F., Ramsey, E., Wright, T. C., Jr., Thomas, L., Matseoane, S., Lazaro, N., Felton, H. T., Sachdev, R. K., Richart, R. M., and Curtin, J. P. Cigarette smoking and cervical dysplasia among non-Hispanic black women. Cancer Detect. Prev., 22: 109-119, 1998.
22. Ferrante, J. M., Gonzalez, E. C., Roetzheim, R. G., Pal, N., and Woodard, L. Clinical and demographic predictors of late-stage cervical cancer. Arch. Fam. Med., 9: 439-445, 2000.
23. Potischman, N., and Brinton, L. A. Nutrition and cervical neoplasia. Cancer Causes Control, 7: 113-126, 1996.
24. Weinstein, S. J., Ziegler, R. G., Selhub, J., Fears, T. R., Strickler, H. D., Brinton, L. A., Hamman, R. F., Levine, R. S., Mallin, K., and Stolley, P. D. Elevated serum homocysteine levels and increased risk of invasive cervical cancer in U. S. women. Cancer Causes Control, 12: 317-324, 2001.
25. Goodman, M. T., McDuffie, K., Hernandez, B., Bertram, C. C., Wilkens, L. R., Guo, C., Seifried, A., Killeen, J., and Le Marchand, L. CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol. Oncol., 81: 263-269, 2001.
26. Wank, R., Meulen, J. T., Luande, J., Eberhardt, H. C., and Pawlita, M. Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602, *301, *0303 alleles. Lancet, 341: 1215, 1993.
27. Gregoire, L., Lawrence, W. D., Kukuruga, D., Eisenbrey, A. B., and Lancaster, W. D. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int. J. Cancer, 57: 504-507, 1994.
28. Apple, R. J., Becker, T. M., Wheeler, C. M., and Erlich, H. A. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J. Natl. Cancer Inst. (Bethesda), 87: 427-436, 1995.
29. Devesa, S. S., Silverman, D. T., Young, J. L., Jr., Pollack, E. S., Brown, C. C., Horm, J. W., Percy, C. L., Myers, M. H., McKay, F. W., and Fraumeni, J. F., Jr. Cancer incidence and mortality trends among whites in the United States, 1947-84. J. Natl. Cancer Inst. (Bethesda), 79: 701-770, 1987.
30. Richart, R. M. Screening. The next century. Cancer (Phila.), 76: 1919-1927, 1995.
31. Solomon, D., Schiffman, M., and Tarone, R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J. Natl. Cancer Inst. (Bethesda), 93: 293-299, 2001.
32. Steller, M. A., and Schiller, J. T. Human papillomavirus immunology and vaccine prospects. J. Natl. Cancer Inst. Monogr., 21: 145-148, 1996.
33. Segnan, N. Socioeconomic status and cancer screening. In: N. P. Kogevinas, M. M. Susser, and P. Boffetta (eds.), Social Inequalities and Cancer, pp. 369-376. Lyon, France: International Agency for Research on Cancer, 1997.
34. Kerner, J. F., Dusenbury, L., and Mandelblatt, J. S. Poverty and cultural diversity: challenges for health promotion among the medically underserved. Annu. Rev. Public Health, 14: 355-377, 1993.
35. Hiatt, R. A., Pasick, R. J., Stewart, S., Bloom, J., Davis, P., Gardiner, P., Johnston, M., Luce, J., Schorr, K., Brunner, W., and Stroud, F. Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev. Med., 33: 190-203, 2001.
36. Henschke, U. K, Leffall, L, D., Jr., Mason, C. H., Reinhold, A. W., Schneider, R. L., and White, J. E. Alarming increase of the cancer mortality in the U. S. black population (1950-1967). Cancer (Phila.), 31: 763-768, 1973.
37. Marcus, A. C., and Crane, L. A. A review of cervical cancer screening intervention research: implications for public health programs and future research. Prev. Med., 27: 13-31, 1998.
38. Thoms, W. W., Unger, E. R., Johnson, P. R., Spann, C. O., Hunter, S. H., Smith, R., Horowitz, I. R., Icenogle, J. P., Vernon, S. D., and Reeves, W. C. Cervical cancer survival in a high risk urban population. Cancer (Phila.), 76: 2518-2523, 1995.
39. Shelton, D., Paturzo, D., Flannery, J., and Gregorio, D. Race, stage of disease, and survival with cervical cancer. Ethn. Dis., 2: 47-54, 1992.
40. Kosary, C. L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin. Surg. Oncol., 10: 31-46, 1994.
41. Perez, C. A., Kurman, R. J., Stehman, F. B., and Thigpen J. T. Uterine cervix. Principles and practice of gynecologic oncology. Philadelphia: J. B. Lippincott, 1992.
42. Bang, K. M., White, J. E., Gause, B. L., and Leffall, L. D., Jr. Evaluation of recent trends in cancer mortality and incidence among blacks. Cancer (Phila.), 61: 1255-1261, 1988.
43. Axtell, L. M., and Myers, M. H. Contrasts in survival of black and white cancer patients, 1960-73. J. Natl. Cancer Inst. (Bethesda), 60: 1209-1215, 1978.
44. Parham, G. P., and Hicks, M. L. Race as a factor in the outcome of patients with cervical cancer: lift the veil to find the wounded spirit. Gynecol. Oncol., 71: 149-150, 1998.
45. American Cancer Society, Inc. ACS: Cancer facts and figures, 1997. Atlanta, GA: The American Cancer Society, Inc., 1997.
46. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1998. CA - Cancer J. Clin., 48: 6-29, 1998.
47. Chao, A., Becker, T. M., Jordan, S. W., Darling, R., Gilliland, F. D., and Key, C. R. Decreasing rates of cervical cancer among American Indians and Hispanics in New Mexico (United States). Cancer Causes Control, 7: 205-213, 1996.
48. McPhee, S. J., and Nguyen, T. T. Cancer, cancer risk factors, and community-based cancer control trials in Vietnamese Americans. Asian Am. Pac. Isl. J. Health, 8: 18-31, 2000.
49. Howell, E. A., Chen, Y. T., and Concato, J. Differences in cervical cancer mortality among black and white women. Obstet. Gynecol., 94: 509-515, 1999.
50. Greenwald, H. P., Polissar, N. L., and Dayal, H. H. Race, socioeconomic status and survival in three female cancers. Ethn, Health, 1: 65-75, 1996.
51. Brooks, S. E., Chen, T. T., Ghosh, A., Mullins, C. D., Gardner, J. F., and Baquet, C. R. Cervical cancer outcomes analysis: impact of age, race, and comorbid illness on hospitalizations for invasive carcinoma of the cervix. Gynecol. Oncol., 79: 107-115, 2000.
52. Breen, N., and Kessler, L. Changes in the use of screening mammography: evidence from the 1987 and 1990 National Health Interview surveys. Am. J. Public Health, 84: 62-67, 1994.
53. Morgan, M. A., Behbakht, K., Benjamin, I., Berlin, M., King, S. A., and Rubin, S. C, Racial differences in survival from gynecologic cancer. Obstet. Gynecol., 88: 914-918, 1996.
54. Farley, J. H., Hines, J. F., Taylor, R. R., Carlson, J. W., Parker, M. F., Kost, E. R., Rogers, S. J., Harrison, T. A., Macri, C. I., and Parham, G. P. Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer (Phila.), 91: 869-873, 2001.
55. Paskett, E. D., Rushing, J., D'Agostino, R., Jr., Tatum, C., and Velez, R. Cancer screening behaviors of low-income women: the impact of race. Womens Health, 3: 203-226, 1997.
56. NCI. Breast and cervical cancer screening among underserved women. Baseline survey results from six states. The National Cancer Institute Cancer Screening Consortium for Underserved Women. Arch. Fam. Med., 4: 617-624, 1995.
57. Gustafsson, L., Ponten, J., Bergstrom, R., and Adami, H. O. International incidence rates of invasive cervical cancer before cytological screening. Int. J. Cancer, 71: 159-165, 1997.
58. Lawson, H. W., Lee, N. C., Thames, S. F., Henson, R., and Miller, D. S. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995. Obstet. Gynecol., 92: 745-752, 1998.
59. Baker, P., Hoel, D., Mohr, L., Lipsitz, S., and Lackland, D. Racial, age, and rural/urban disparity in cervical cancer incidence. Ann. Epidemiol., 10: 466-467, 2000.
60. Harris, R., and Leininger, L. Preventive care in rural primary care practice. Cancer (Phila.), 72: 1113-1118, 1993.
61. Riley, G. F., Potosky, A. L., Lubitz, J. D., and Brown, M. L. Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am. J. Public Health, 84: 1598-1604, 1994.
62. Krieger, N., Quesenberry, C., Jr., Peng, T., Hom-Ross, P., Stewart, S., Brown, S., Swallen, K., Guillermo, T., Suh, D., Alvarez-Martinez, L., and Ward, F. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control, 10: 525-537, 1999.
63. Liu, L., Deapen, D., and Bernstein, L. Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer Causes Control, 9: 369-380, 1998.
64. Kiefe, C. I., Funkhouser, E., Fouad, M. N., and May, D. S. Chronic disease as a barrier to breast and cervical cancer screening. J. Gen. Intern. Med., 13: 357-365, 1998.
65. Mundt, A. J., Connell. P. P., Campbell, T., Hwang, J. H., Rotmensch, J., and Waggoner, S. Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol. Oncol., 71: 151-158, 1998.
66. Katz, A., Eifel. P. J., Moughan, J., Owen, J. B., Mahon, I., and Hanks. G. E. Socioeconomic characteristics of patients with squamous cell carcinoma of the uterine cervix treated with radiotherapy in the 1992 to 1994 patterns of care study. Int. J. Radiat. Oncol. Biol. Phys., 47: 443-450, 2000.
67. Grogan, M., Thomas, G. M., Melamed, I., Wong, F. L., Pearcey, R. G., Joseph, P. K., Portelance, L., Crook, J., and Jones, K. D. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer (Phila.), 86: 1528-1536, 1999.
68. Obermair, A., Cheuk, R., Horwood, K., Janda, M., Bachtiary, B., Schwanzelberger, B., Stoiber, A., Nicklin, J. L., Perrin, L. C., and Crandon, A. J. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results. Cancer (Phila.), 92: 903-908, 2001.
69. Orbell, S., Crombie, I., Robertson, A., Johnston, G., and Kenicer, M. Assessing the effectiveness of a screening campaign: who is missed by 80% cervical screening coverage? J. R. Soc. Med., 88: 389-394, 1995.
70. Makuc, D. M., Freid, V. M., and Kleinman, J. C. National trends in the use of preventive health care by women. Am. J. Public Health, 79: 21-26, 1989.
71. Fahs, M. C. Relationships among insurance coverage, access to services and health outcomes: case study of cervical cancer and African American women. K. Garibaldi (ed.). Washington, D. C.: Office of Technology Assessment, U. S. Congress, 1992.
72. Spitzer, M., Chernys, A. E., and Seltzer, V. L. The use of large-loop excision of the transformation zone in an inner-city population. Obstet. Gynecol., 82: 731-735, 1993.
73. Santos, C., Galdos, R., Alvarez, M., Velarde, C., Barriga, O., Dyer, R., Estrada, H., and Almonte, M. One-session management of cervical intraepithelial neoplasia: a solution for developing countries. Gynecol. Oncol., 61: 11-15, 1996.
74. Thoms, W. W., Unger, E. R., Carisio, R., Nisenbaum, R., Spann, C. O., Horowitz, I. R., and Reeves, W. C. Clinical determinants of survival from stage Ib cervical cancer in an inner-city hospital. J. Natl. Med. Assoc., 90: 303-308, 1998.
75. Parham, G. P., and Hicks, M. L. Gynecologic cancer among the socioeconomically disadvantaged. Cancer (Phila.), 76: 2176-2180, 1995.
76. Hicks, M. L., Kim, W., Abrams, J., Johnson, C. C., Blount, A. C., and Parham, G. P. Racial differences in surgically staged patients with endometrial cancer. J. Natl. Med. Assoc., 89: 134-140, 1997.
77. Dedier, J., Penson, R., Williams, W., and Lynch, T., Jr. Race, ethnicity, and the patient-caregiver relationship. Oncologist, 4: 325-331, 1999.
78. Bach, P. B., Cramer, L. D., Warren, J. L., and Begg, C. B. Racial differences in the treatment of early-stage lung cancer. N. Engl. J. Med., 341: 1198-1205, 1999.
79. Krieger, N., Rowley, D. L., Herman, A. A., Avery, B., and Phillips, M. T. Racism, sexism, and social class: implications for studies of health, disease, and well-being. Am. J. Prev. Med., 9: 82-122, 1993.
80. Kogevinas, M., Pearce, N., Susser, M., and Boffetta P. (eds.). Social inequalities and cancer. IARC Scientific Publications. Lyon: International Agency for Research on Cancer/World Health Organization, 1997.
81. Williams, D. R., and Collins, C. U. S. socioeconomic and racial differences in health: patterns and explanations. Annu. Rev. Sociol., 21: 349-386, 1995.
82. Pasick, R. J., Sabogal, F., and Bird, J. Problems and progress in development and translation of health survey questions across ethnic groups: the pathways experience. Health Educ. Q., 23(s): S28-S40, 1996.
83. Becker, T. M., Wheeler, C. M., McPherson, R. S., Kratochvil, A., Parmenter, C. A., North, C. Q., and Miller, J. A. Risk factors for cervical dysplasia in southwestern American Indian women: a pilot study. Alaska Med., 35: 255-263, 1993.
84. Paskett, E. D., Tatum, C. M., D'Agostino, R., Rushing, J., Velez, R., Michielutte, R., and Dignan, M. Community-based interventions to improve breast and cervical cancer screening: results of the Forsyth County Cancer Screening (FoCaS) project. Cancer Epidemiol. Biomark. Prev., 8: 453-459, 1999.
85. Burack, R. C., Gimotty, P. A., George, J., McBride, S., Moncrease, A., Simon, M. S., Dews, P., and Coombs, J. How reminders given to patients and physicians affected pap smear use in a health maintenance organization: results of a randomized controlled trial. Cancer (Phila.), 82: 2391-2400, 1998.
86. Public Health Service. The clinical laboratory improvement amendments of 1988, 353, Public Health Service Act, as amended at 42 USC 263a, 1988.
87. Montz, F. J. Use of the "see and treat" loop electrical excision procedure: a new standard or just more controversy? Postgrad. Obstet. Gynecol., 16: 1-6, 1996.
88. Holschneider, C. H., Ghosh, K., and Montz, F. J. See-and-treat in the management of high-grade squamous intraepithelial lesions of the cervix: a resource utilization analysis. Obstet. Gynecol., 94: 377-385, 1999.
89. Goldie, S. J., Kuhn, L., Denny, L., Pollack, A., and Wright, T. C. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. J. Am. Med. Assoc., 285: 3107-3115, 2001.
90. Meissner, H. I., Breen, N., Coyne, C., Legler, J. M., Green, D. T., and Edwards, B. K. Breast and cervical cancer screening interventions: an assessment of the literature. Cancer Epidemiol. Biomark. Prev., 7: 951-961, 1998.